Incyte price target raised to $68 from $62 at Wells Fargo
PremiumThe FlyIncyte price target raised to $68 from $62 at Wells Fargo
3d ago
Incyte price target raised to $97 from $92 at Citi
Premium
The Fly
Incyte price target raised to $97 from $92 at Citi
3d ago
Incyte’s Q3 2024: Strong Revenue and Clinical Progress
Premium
Company Announcements
Incyte’s Q3 2024: Strong Revenue and Clinical Progress
3d ago
INCY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsINCY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6d ago
Innate Pharma appoints Jonathan Dickinson as CEO
Premium
The Fly
Innate Pharma appoints Jonathan Dickinson as CEO
19d ago
Wolfe Research starts Incyte at Outperform amid ‘major push’ in I&I
Premium
The Fly
Wolfe Research starts Incyte at Outperform amid ‘major push’ in I&I
1M ago
Incyte price target raised to $92 from $86 at Guggenheim
PremiumThe FlyIncyte price target raised to $92 from $86 at Guggenheim
2M ago
Incyte price target raised to $68 from $66 at BofA
Premium
The Fly
Incyte price target raised to $68 from $66 at BofA
2M ago
Incyte announces new early clinical data for INCB123667
Premium
The Fly
Incyte announces new early clinical data for INCB123667
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100